D&D Pharmatech Announces Sponsored Research Agreement with Yale University to Optimize Novel Strategies for the Treatment of Brain Cancer and Other Diseases of the Central Nervous System
VEGF-C shown to circumvent barriers in the brain’s lymphatic system; combination of VEGF-C and a…